Kyowa Kirin and Hisamitsu link up for sublingual fentanyl
This article was originally published in Scrip
Executive Summary
Kyowa Hakko Kirin and Hisamitsu have entered into an agreement for the joint distribution and promotion of a sublingual formulation of fentanyl citrate in Japan for the treatment of breakthrough pain in cancer patients.